Newsmeme!
Discover News you didn't know existed
Restriction enzyme
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Longevity pill on the horizon?
Published July 9, 2009, 4:13 pm, UW News
While applauding findings that an Easter Island compound extends the lives of middle-aged mice, University of Washington (UW) longevity researchers caution that healthy people shouldn't start taking the drug in the hopes of extending their own life spans -- at least not yet.
Calorie-Restricted Diets and Other Ways to Avoid Aging
Published July 9, 2009, 9:01 am, US News & World Report
New research shows we can ward off diabetes, cancer, and heart disease to stay younger than our years.
Easter Island drug makes Methuselah mice
Published July 9, 2009, 5:39 am, Manila Bulletin
PARIS, July 8, 2009 (AFP) - A compound found in the soil of Easter Island stunningly boosts the lifespan of mice, enabling some to live more than 100 years old in human terms, researchers reported on Wednesday.
Easter Island molecule 'boosts lifespan'
Published July 8, 2009, 2:48 pm, The Age
A compound in the soil of Easter Island stunningly boosts the lifespan of mice, enabling some to live more than 100 years old in human terms, researchers said.
Easter Island drug 'boosts lifespan'
Published July 8, 2009, 12:33 pm, Adelaide Now
A COMPOUND found in the soil of Easter Island stunningly boosts the lifespan of mice, enabling some to live more than 100 years old in human terms, researchers reported today.
'Fountain of youth' found
Published July 8, 2009, 12:33 pm, The Courier Mail
A MIRACULOUS "fountain of youth" drug that could potentially extend people's life spans by more than a decade has been developed by scientists.
Cancer Drug Delays Aging in Mice
Published July 8, 2009, 11:09 am, Wired News
A drug approved for treating cancer also can extend the life of elderly mice. Though the drug is not likely to be tested in humans because of its immunosuppressant effects, it suggests that it is possible to slow aging, even if treatment is started later in life.
My Pharmiweb.com
Published July 8, 2009, 2:04 am, PharmiWeb
Lexington, Massachusetts, US – July 6th, 2009 – Shire plc (LSE: SHP, NASDAQ:SHPGY), the global specialty biopharmaceutical company, announces that, at the request of the FDA, in view of a potential restriction on the availability of the current approved and marketed treatment for Gaucher Disease patients, it has filed a treatment protocol for velaglucerase alfa, its enzyme replacement therapy in ...
Shire to offer alternative to shelved Genzyme drug
Published July 7, 2009, 9:58 am, Mass High Tech: The Journal of New England Technology
Shire plc has filed a treatment protocol with the U.S. Food and Drug Administration for velaglucerase alfa, its enzyme replacement therapy in development for the treatment of Gaucher Disease.
Shire Has Filed A Treatment Protocol For Velaglucerase Alfa For Gaucher Disease
Published July 7, 2009, 4:14 am, Medical News Today
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that, at the request of the FDA, in view of a potential restriction on the availability of the current approved and marketed treatment for Gaucher Disease patients, it has filed a treatment protocol for ve
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |